India Says More Than Half Of Drug Maker Group Failed To File Pricing Data
This article was originally published in PharmAsia News
Executive Summary
Fifty-five drugs face elimination from India's watchdog list of antibiotics, painkillers and other formulations set for price caps because their manufacturers failed to supply information as required.